US tariff heat: Fitch says Indian firms face limited direct hit; pharma sector seen at risk if duties widen
Fitch Ratings cautions that while Indian corporates have limited direct exposure to current US tariffs, sectors like pharmaceuticals could face risks if further measures are ...
FM Sitharaman: India not a tariff king, rates lower than approved
India’s Trade Story: Shedding the “Tariff King” Label For years, whispers have circulated internationally, painting India as a protectionist nation, a “tariff king” jealously guarding ...
